Sahlgrenska University Hospital
Gothenburg, 41132, Sweden
NCT Number: NCT02086669
Patients with newly diagnosed achalasia have been submitted to either treatment with pneumatic dilatation or surgical myotomy. Minimal follow up five years.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Phase 2
Gothenburg, 41132, Sweden
Patients with newly diagnosed achalasia have been submitted to either treatment with pneumatic dilatation or surgical myotomy. Minimal follow up five years.
During follow up patients have been interviewed with regular intervals, by use validated questionnaires. The level of symptom control has been assessed as well as the scoring cumulative incidence of treatment failures.
Health Related Quality of Life (HRQL) has been regularly checked.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: At least five years after intervention
Treatment failure is defined as a Composite variabel containing a number of different Clinically relevant outcomes.
Time frame: At least five years after intervention
Dysphagia score according to standardized, validated scoring system.
Time frame: At least five years after intervention.
Universally adopted and validated instruments are used.
Time frame: At least five years after intervention.
Charges for the average hospital in respective countries.
Karolinska University Hospital
Other
Randomized Study to Compare Pneumatic Dilatation With Surgical Myotomy for Treatment of Achalasia - Long Term Follow up
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05772260
Achalasia, Deglutition Disorders
Seoul, South Korea
View Trial DetailsNCT03063463
Achalasia, Deglutition Disorders
Nashville, Tennessee, United States
View Trial DetailsNCT01793922
Achalasia, Deglutition Disorders
Leuven, Belgium
View Trial DetailsNCT01512719
Achalasia, Deglutition Disorders
Jerusalem, Israel
View Trial Details